Experimental in vitro efficacy study on the interaction of epiroprim plus isoniazid against Mycobacterium tuberculosis

Chemotherapy

Volumn 47, Issue 2, 2001, Pages 123-127

  Dosso, Mireille ^a   Ouattara, Lassina ^b   Cherif, Abdou Magid ^b   Bouzid, Samir Amor ^a   Haller, Louis ^c   Fernex, Michel ^c  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b UFR DES Sciences Pharmaceutiques and Biologiques   (Côte d’Ivoire)

^c Roche African Research Foundation   (Côte d’Ivoire)

Author keywords

Epiroprim; Experimental in vitro study; Isoniazid; Mycobacterium tuberculosis

Indexed keywords

EPIROPRIM; ISONIAZID;

ARTICLE; DRUG EFFICACY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTITUBERCULAR AGENTS; DRUG SYNERGISM; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; TRIMETHOPRIM;

EID: 0035121462     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048511     Document Type: Article

References (17)

1. The mortality and pathology of HIV infection in a west African city
2. Natural history and spectrum of disease in adults with HIV/AIDS in Africa
3. Life-threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya
4. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Côte d'Ivoire
5. Isoniazid plus sulphadoxine-pyrimethamine can reduce morbidity of HIV-positive patients treated for tuberculosis in Africa: A controlled clinical trial
6. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: A randomized controlled trial
7. Epiroprim (Ro 11-8958)
8. A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models
9. Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii
10. Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone
11. Technique du test de sensibilité de Mycobacterium tuberculosis aux drogues antibacillaires par la méthode des proportions
12. La détermination de la sensibilité de Mycobacterium tuberculosis aux agents antituberculeux
13. L'antibiogramme: Association d'antibiotiques
14. Chimiothérapie de la tuberculose et de la lèpre
15. Mécanismes de résistance aux antituberculeux